Skip to main content
AAN.com
Articles
February 1, 1999

The Autonomic Symptom Profile
A new instrument to assess autonomic symptoms

February 1, 1999 issue
52 (3) 523

Abstract

Objective: To develop a new specific instrument called the Autonomic Symptom Profile to measure autonomic symptoms and test its validity.
Background: Measuring symptoms is important in the evaluation of quality of life outcomes. There is no validated, self-completed questionnaire on the symptoms of patients with autonomic disorders.
Methods: The questionnaire is 169 items concerning different aspects of autonomic symptoms. The Composite Autonomic Symptom Scale (COMPASS) with item-weighting was established; higher scores indicate more or worse symptoms. Autonomic function tests were performed to generate the Composite Autonomic Scoring Scale (CASS) and to quantify autonomic deficits. We compared the results of the COMPASS with the CASS derived from the Autonomic Reflex Screen to evaluate validity.
Results: The instrument was tested in 41 healthy controls (mean age 46.6 years), 33 patients with nonautonomic peripheral neuropathies (mean age 59.5 years), and 39 patients with autonomic failure (mean age 61.1 years). COMPASS scores correlated well with the CASS, demonstrating an acceptable level of content and criterion validity. The mean (±SD) overall COMPASS score was 9.8 (±9) in controls, 25.9 (±17.9) in the patients with nonautonomic peripheral neuropathies, and 52.3 (±24.2) in the autonomic failure group. Scores of symptoms of orthostatic intolerance and secretomotor dysfunction best predicted the CASS on multiple stepwise regression analysis.
Conclusions: We describe a questionnaire that measures autonomic symptoms and present evidence for its validity. The instrument shows promise in assessing autonomic symptoms in clinical trials and epidemiologic studies.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Dyck PJ, Karnes J, O’Brien PC, Swanson CJ. Neuropathy Symptom Profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis. Neurology 1986;36:1300–1308.
2.
Low PA, Opfer-Gehrking TL, McPhee BR, et al. Prospective evaluation of clinical characteristics of orthostatic hypotension. Mayo Clin Proc 1995;70:617–622.
3.
Low PA. Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. Mayo Clin Proc 1993;68:748–752.
4.
Low PA. Laboratory evaluation of autonomic function. In: Low PA, ed. Clinical autonomic disorders: evaluation and management. 2nd ed. Philadelphia:Lippincott-Raven, 1997:179–208.
5.
Low PA, Pfeifer MA. Standardization of autonomic function. In: Low PA, ed. Clinical autonomic disorders: evaluation and management. 2nd ed. Philadelphia:Lippincott-Raven, 1997:287–295.
6.
O’Gorman TW, Woolson RF. Using Kendall’s tau b correlations to improve variable selection methods in case-control studies. Biometrics 1995;51:1451–1460.
7.
Suarez GA, Fealey RD, Camilleri M, Low PA. Idiopathic autonomic neuropathy : clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology 1994;44:1675–1682.
8.
Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med 1980;49:95–108.
9.
Fernandez-Castaner M, Mendola G, Levy I, Gomis R, Figuerola D. Prevalence and clinical aspects of cardiovascular vegetative neuropathy in a diabetic population. Med Clin (Barc) 1985;84:215–218.
10.
Ewing DJ, Campbell IW, Clarke BF. Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. Ann Intern Med 1980;92:308–311.
11.
Chambers JB, Sampson MJ, Sprigings DC, Jackson G. QT prolongation on the electrocardiogram in diabetic autonomic neuropathy [see comments]. Diabet Med 1990;7:105–110.
12.
Burgos LG, Ebert TJ, Asiddao C, et al. Increased intraoperative cardiovascular morbidity in diabetics with autonomic neuropathy. Anesthesiology 1989;70:591–597.
13.
Knuttgen D, Weidemann D, Doehn M. Diabetic autonomic neuropathy : abnormal cardiovascular reactions under general anesthesia. Klin Wochenschr 1990;68:1168–1172.
14.
Fagius J, Brattberg A, Jameson S, Berne C. Limited benefit of treatment of diabetic polyneuropathy with an aldose reductase inhibitor : a 24-week controlled trial. Diabetologia 1985;28:323–329.
15.
McEvoy KM, Windebank AJ, Daube JR, Low PA. 3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome. N Engl J Med 1989;321:1567–1571.

Information & Authors

Information

Published In

Neurology®
Volume 52Number 3February 1, 1999
Pages: 523
PubMed: 10025781

Publication History

Received: April 22, 1998
Accepted: October 17, 1998
Published online: February 1, 1999
Published in print: February 1, 1999

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

G.A. Suarez, MD
From the Autonomic Reflex Laboratory (Drs. Suarez and Lowand T.L. Opfer-Gehrking), Department of Neurology, and Section of Biostatistics (Dr. O’Brien, and K.P. Offord and E.J. Atkinson), Mayo Clinic, Rochester, MN.
T.L. Opfer-Gehrking
From the Autonomic Reflex Laboratory (Drs. Suarez and Lowand T.L. Opfer-Gehrking), Department of Neurology, and Section of Biostatistics (Dr. O’Brien, and K.P. Offord and E.J. Atkinson), Mayo Clinic, Rochester, MN.
K.P. Offord, MS
From the Autonomic Reflex Laboratory (Drs. Suarez and Lowand T.L. Opfer-Gehrking), Department of Neurology, and Section of Biostatistics (Dr. O’Brien, and K.P. Offord and E.J. Atkinson), Mayo Clinic, Rochester, MN.
E.J. Atkinson, MS
From the Autonomic Reflex Laboratory (Drs. Suarez and Lowand T.L. Opfer-Gehrking), Department of Neurology, and Section of Biostatistics (Dr. O’Brien, and K.P. Offord and E.J. Atkinson), Mayo Clinic, Rochester, MN.
P.C. O’Brien, PhD
From the Autonomic Reflex Laboratory (Drs. Suarez and Lowand T.L. Opfer-Gehrking), Department of Neurology, and Section of Biostatistics (Dr. O’Brien, and K.P. Offord and E.J. Atkinson), Mayo Clinic, Rochester, MN.
P.A. Low, MD
From the Autonomic Reflex Laboratory (Drs. Suarez and Lowand T.L. Opfer-Gehrking), Department of Neurology, and Section of Biostatistics (Dr. O’Brien, and K.P. Offord and E.J. Atkinson), Mayo Clinic, Rochester, MN.

Notes

Address correspondence and reprint requests to Dr. Guillermo A. Suarez, Department of Neurology, Mayo Clinic, 811 Guggenheim Building, 200 First Street SW, Rochester, MN 55905.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Assessing the Feasibility of Using Electrochemical Skin Conductance as a Substitute for the Quantitative Sudomotor Axon Reflex Test in the Composite Autonomic Scoring Scale and Its Correlation with Composite Autonomic Symptom Scale 31 in Parkinson’s Disease, Journal of Clinical Medicine, 12, 4, (1517), (2023).https://doi.org/10.3390/jcm12041517
    Crossref
  2. Evaluation of Autonomic Nervous System Dysfunction in Childhood Obesity and Prader–Willi Syndrome, International Journal of Molecular Sciences, 24, 9, (8013), (2023).https://doi.org/10.3390/ijms24098013
    Crossref
  3. Refractory Hypotension in a Late-Onset Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS) Male with m.3243 A>G Mutation: A Case Report, Brain Sciences, 13, 7, (1080), (2023).https://doi.org/10.3390/brainsci13071080
    Crossref
  4. Depression in Sjögren’s syndrome mediates the relationship between pain, fatigue, sleepiness, and overall quality of life, Rheumatology and Immunology Research, 4, 2, (78-89), (2023).https://doi.org/10.2478/rir-2023-0012
    Crossref
  5. The Principal Components of Autonomic Dysfunction in Fibromyalgia Assessed by the Refined and Abbreviated Composite Autonomic Symptom Score, Reviews on Recent Clinical Trials, 18, 2, (140-145), (2023).https://doi.org/10.2174/1574887118666230315120413
    Crossref
  6. Autonome Diagnostik bei der Amyotrophen Lateralsklerose, Klinische Neurophysiologie, 54, 01, (22-27), (2023).https://doi.org/10.1055/a-2018-3174
    Crossref
  7. Construct validity of the international standards to document remaining autonomic function after spinal cord injury (ISAFSCI) (1st edition), Spinal Cord, 61, 12, (644-651), (2023).https://doi.org/10.1038/s41393-023-00932-z
    Crossref
  8. Assessment of autonomic symptom scales in patients with neurodevelopmental diagnoses using electronic health record data, Research in Autism Spectrum Disorders, 108, (102234), (2023).https://doi.org/10.1016/j.rasd.2023.102234
    Crossref
  9. The Long-COVID autonomic syndrome in hospitalized patients: A one-year prospective cohort study, European Journal of Internal Medicine, (2023).https://doi.org/10.1016/j.ejim.2023.08.018
    Crossref
  10. Self-reported symptom burden in postural orthostatic tachycardia syndrome (POTS): A narrative review of observational and interventional studies, Autonomic Neuroscience, 244, (103052), (2023).https://doi.org/10.1016/j.autneu.2022.103052
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to get full access to it.

Purchase Access, $39 for 24hr of access

View options

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share